Ardelik (ARDX) on Xphozah’s orphan designation for hyperphosphatemia
Ardelik, Inc. ARDX announced that the FDA granted orphan designation to Xphozah (tenapanor) for the treatment of hyperphosphatemia in children. Xphozah is an Ardelix twice-daily oral tablet with a novel …